contest

A crucial bidding war for weight-loss drugs: Pfizer may raise its bid to compete with Novo Nordisk for Metsera.

The bidding war surrounding obesity biotechnology company Metsera is intensifying, with reports indicating that Pfizer....

Stock
2026-01-12
A crucial bidding war for weight-loss drugs: Pfizer may raise its bid to compete with Novo Nordisk for Metsera.